The role of miRNAs and EBV BARTs in NPC

Seminars in Cancer Biology

Volumn 22, Issue 2, 2012, Pages 166-172

  Marquitz, Aron R ^a   Raab Traub, Nancy ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

BARTs; EBV; MiRNAs; NPC

Indexed keywords

MICRORNA; NOTCH RECEPTOR; ONCOPROTEIN; PROTEIN A73; PROTEIN BART; PROTEIN RPMS1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

3' UNTRANSLATED REGION; AMINO TERMINAL SEQUENCE; BINDING SITE; CALCIUM TRANSPORT; CARCINOGENESIS; DNA METHYLATION; DOWN REGULATION; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE PRODUCT; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; IMMUNOPRECIPITATION; NASOPHARYNX CARCINOMA; NONHUMAN; OPEN READING FRAME; POLYADENYLATION; PROMOTER REGION; REVIEW; SIGNAL TRANSDUCTION; STOP CODON; TRANSCRIPTION INITIATION SITE;

APOPTOSIS REGULATORY PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; MICRORNAS; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; NASOPHARYNGEAL NEOPLASMS; PROTO-ONCOGENE PROTEINS; RNA, VIRAL;

EID: 84857788528     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2011.12.001     Document Type: Review

References (76)

1. Henle G., Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 1976, 17:1-7.
2. Raab-Traub N., Flynn K., Pearson G., Huang A., Levine P., Lanier A., et al. The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer 1987, 39:25-29.
3. Wolf H., Zur Hausen H., Klein G., Becker V., Henle G., Henle W. Attempts to detect virus-specific DNA sequences in human tumors. III. Epstein-Barr viral DNA in non-lymphoid nasopharyngeal carcinoma cells. Med Microbiol Immunol 1975, 161:15-21.
4. Pathmanathan R., Prasad U., Sadler R., Flynn K., Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995, 333:693-698.
5. Young L.S., Dawson C.W., Clark D., Rupani H., Busson P., Tursz T., et al. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 1988, 69(Pt 5):1051-1065.
6. Busson P., McCoy R., Sadler R., Gilligan K., Tursz T., Raab-Traub N. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J Virol 1992, 66:3257-3262.
7. Sam C.K., Brooks L.A., Niedobitek G., Young L.S., Prasad U., Rickinson A.B. Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma. Int J Cancer 1993, 53:957-962.
8. Decaussin G., Sbih-Lammali F., de Turenne-Tessier M., Bouguermouh A., Ooka T. Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies. Cancer Res 2000, 60:5584-5588.
9. Seto E., Yang L., Middeldorp J., Sheen T.S., Chen J.Y., Fukayama M., et al. Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. J Med Virol 2005, 76:82-88.
10. Gilligan K.J., Rajadurai P., Lin J.C., Busson P., Abdel-Hamid M., Prasad U., et al. Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J Virol 1991, 65:6252-6259.
11. Sadler R.H., Raab-Traub N. Structural analyses of the Epstein-Barr virus BamHI A transcripts. J Virol 1995, 69:1132-1141.
12. Busson P., Ganem G., Flores P., Mugneret F., Clausse B., Caillou B., et al. Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int J Cancer 1988, 42:599-606.
13. Gilligan K., Sato H., Rajadurai P., Busson P., Young L., Rickinson A., et al. Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J Virol 1990, 64:4948-4956.
14. Hitt M.M., Allday M.J., Hara T., Karran L., Jones M.D., Busson P., et al. EBV gene expression in an NPC-related tumour. EMBO J 1989, 8:2639-2651.
15. Karran L., Gao Y., Smith P.R., Griffin B.E. Expression of a family of complementary-strand transcripts in Epstein-Barr virus-infected cells. Proc Natl Acad Sci USA 1992, 89:8058-8062.
16. Dambaugh T., Nkrumah F.K., Biggar R.J., Kieff E. Epstein-Barr virus RNA in Burkitt tumor tissue. Cell 1979, 16:313-322.
17. Raab-Traub N., Hood R., Yang C.S., Henry B., Pagano J.S. Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol 1983, 48:580-590.
18. Brooks L.A., Lear A.L., Young L.S., Rickinson A.B. Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency. J Virol 1993, 67:3182-3190.
19. Sugiura M., Imai S., Tokunaga M., Koizumi S., Uchizawa M., Okamoto K., et al. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells. Br J Cancer 1996, 74:625-631.
20. Raab-Traub N., Dambaugh T., Kieff E. DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative. Cell 1980, 22:257-267.
21. Robertson E.S., Tomkinson B., Kieff E. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro. J Virol 1994, 68:1449-1458.
22. Edwards R.H., Marquitz A.R., Raab-Traub N. Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. J Virol 2008, 82:9094-9106.
23. Smith P.R., de Jesus O., Turner D., Hollyoake M., Karstegl C.E., Griffin B.E., et al. Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus. J Virol 2000, 74:3082-3092.
24. Smith P.R., Gao Y., Karran L., Jones M.D., Snudden D., Griffin B.E. Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors. J Virol 1993, 67:3217-3225.
25. Chen H., Huang J., Wu F.Y., Liao G., Hutt-Fletcher L., Hayward S.D. Regulation of expression of the Epstein-Barr virus BamHI-A rightward transcripts. J Virol 2005, 79:1724-1733.
26. Salamon D., Takacs M., Ujvari D., Uhlig J., Wolf H., Minarovits J., et al. Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus. J Virol 2001, 75:2584-2596.
27. Al-Mozaini M., Bodelon G., Karstegl C.E., Jin B., Al-Ahdal M., Farrell P.J. Epstein-Barr virus BART gene expression. J Gen Virol 2009, 90:307-316.
28. de Jesus O., Smith P.R., Spender L.C., Elgueta Karstegl C., Niller H.H., Huang D., et al. Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J Gen Virol 2003, 84:1443-1450.
29. Kim D.N., Song Y.J., Lee S.K. The role of promoter methylation in Epstein-Barr Virus MicroRNA expression in EBV-infected B cell lines. Exp Mol Med 2011.
30. Kienzle N., Sculley T.B., Poulsen L., Buck M., Cross S., Raab-Traub N., et al. Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression. J Virol 1998, 72:6614-6620.
31. Fries K.L., Sculley T.B., Webster-Cyriaque J., Rajadurai P., Sadler R.H., Raab-Traub N. Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus. J Virol 1997, 71:2765-2771.
32. Kienzle N., Buck M., Greco S., Krauer K., Sculley T.B. Epstein-Barr virus-encoded RK-BARF0 protein expression. J Virol 1999, 73:8902-8906.
33. Schroder W., Kienzle N., Bushell G., Sculley T. Antiserum raised against the Epstein-Barr virus BARF0 protein reacts to HLA-DR beta chain. Arch Virol 2002, 147:723-729.
34. Thornburg N.J., Kusano S., Raab-Traub N. Identification of Epstein-Barr virus RK-BARF0-interacting proteins and characterization of expression pattern. J Virol 2004, 78:12848-12856.
35. Kusano S., Raab-Traub N. An Epstein-Barr virus protein interacts with Notch. J Virol 2001, 75:384-395.
36. Grossman S.R., Johannsen E., Tong X., Yalamanchili R., Kieff E. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proc Natl Acad Sci USA 1994, 91:7568-7572.
37. Henkel T., Ling P.D., Hayward S.D., Peterson M.G. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science 1994, 265:92-95.
38. Hofelmayr H., Strobl L.J., Stein C., Laux G., Marschall G., Bornkamm G.W., et al. Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters. J Virol 1999, 73:2770-2780.
39. Li A., Zhang X.S., Jiang J.H., Wang H.H., Liu X.Q., Pan Z.G., et al. Transcriptional expression of RPMS1 in nasopharyngeal carcinoma and its oncogenic potential. Cell Cycle 2005, 4:304-309.
40. Chen H., Smith P., Ambinder R.F., Hayward S.D. Expression of Epstein-Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood. Blood 1999, 93:3026-3032.
41. Zhang J., Chen H., Weinmaster G., Hayward S.D. Epstein-Barr virus BamHi-a rightward transcript-encoded RPMS protein interacts with the CBF1-associated corepressor CIR to negatively regulate the activity of EBNA2 and NotchIC. J Virol 2001, 75:2946-2956.
42. Ranganathan P., Weaver K.L., Capobianco A.J. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 2011, 11:338-351.
43. Pfeffer S., Zavolan M., Grasser F.A., Chien M., Russo J.J., Ju J., et al. Identification of virus-encoded microRNAs. Science 2004, 304:734-736.
44. Cai X., Schafer A., Lu S., Bilello J.P., Desrosiers R.C., Edwards R., et al. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2006, 2:e23.
45. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
46. Grundhoff A., Sullivan C.S., Ganem D. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 2006, 12:733-750.
47. Zhu J.Y., Pfuhl T., Motsch N., Barth S., Nicholls J., Grasser F., et al. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol 2009, 83:3333-3341.
48. Chen S.J., Chen G.H., Chen Y.H., Liu C.Y., Chang K.P., Chang Y.S., et al. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS One 2010, 5:e12745.
49. Chen C., Ridzon D.A., Broomer A.J., Zhou Z., Lee D.H., Nguyen J.T., et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005, 33:e179.
50. Amoroso R., Fitzsimmons L., Thomas W.A., Kelly G.L., Rowe M., Bell A.I. Quantitative studies of Epstein-Barr virus-encoded miRNAs provide novel insights into their regulation. J Virol 2011, 85:996-1010.
51. Cosmopoulos K., Pegtel M., Hawkins J., Moffett H., Novina C., Middeldorp J., et al. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J Virol 2009, 83:2357-2367.
52. Pratt Z.L., Kuzembayeva M., Sengupta S., Sugden B. The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. Virology 2009, 386:387-397.
53. Wong A.M., Kong K.L., Tsang J.W., Kwong D.L., Guan X.Y. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer 2011.
54. Lung R.W., Tong J.H., Sung Y.M., Leung P.S., Ng D.C., Chau S.L., et al. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia 2009, 11:1174-1184.
55. Hafner M., Renwick N., Brown M., Mihailovic A., Holoch D., Lin C., et al. RNA-ligase-dependent biases in miRNA representation in deep-sequenced small RNA cDNA libraries. RNA 2011, 17.
56. Denli A.M., Tops B.B., Plasterk R.H., Ketting R.F., Hannon G.J. Processing of primary microRNAs by the microprocessor complex. Nature 2004, 432:231-235.
57. Barth S., Pfuhl T., Mamiani A., Ehses C., Roemer K., Kremmer E., et al. Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res 2008, 36:666-675.
58. Lo A.K., To K.F., Lo K.W., Lung R.W., Hui J.W., Liao G., et al. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad Sci USA 2007, 104:16164-16169.
59. Choy E.Y., Siu K.L., Kok K.H., Lung R.W., Tsang C.M., To K.F., et al. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med 2008, 205:2551-2560.
60. Marquitz A.R., Mathur A., Nam C.S., Raab-Traub N. The Epstein-Barr virus BART microRNAs target the pro-apoptotic protein Bim. Virology 2011, 412:392-400.
61. Petrocca F., Visone R., Onelli M.R., Shah M.H., Nicoloso M.S., de Martino I., et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008, 13:272-286.
62. Terasawa K., Ichimura A., Sato F., Shimizu K., Tsujimoto G. Sustained activation of ERK1/2 by NGF induces microRNA-221 and 222 in PC12 cells. FEBS J 2009, 276:3269-3276.
63. Ventura A., Young A.G., Winslow M.M., Lintault L., Meissner A., Erkeland S.J., et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008, 132:875-886.
64. Dolken L., Malterer G., Erhard F., Kothe S., Friedel C.C., Suffert G., et al. Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 2010, 7:324-334.
65. Bellot G., Cartron P.F., Er E., Oliver L., Juin P., Armstrong L.C., et al. TOM22, a core component of the mitochondria outer membrane protein translocation pore, is a mitochondrial receptor for the proapoptotic protein Bax. Cell Death Differ 2007, 14:785-794.
66. Iizasa H., Wulff B.E., Alla N.R., Maragkakis M., Megraw M., Hatzigeorgiou A., et al. Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. J Biol Chem 2010, 285:33358-33370.
67. Nachmani D., Stern-Ginossar N., Sarid R., Mandelboim O. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 2009, 5:376-385.
68. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18:997-1006.
69. Lawrie C.H., Gal S., Dunlop H.M., Pushkaran B., Liggins A.P., Pulford K., et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008, 141:672-675.
70. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008, 105:10513-10518.
71. Gourzones C., Gelin A., Bombik I., Klibi J., Verillaud B., Guigay J., et al. Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. Virol J 2010, 7:271.
72. Brase J.C., Wuttig D., Kuner R., Sultmann H. Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer 2010, 9:306.
73. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9:654-659.
74. Meckes D.G., Shair K.H., Marquitz A.R., Kung C.P., Edwards R.H., Raab-Traub N. Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci USA 2010, 107:20370-20375.
75. Pegtel D.M., Cosmopoulos K., Thorley-Lawson D.A., van Eijndhoven M.A., Hopmans E.S., Lindenberg J.L., et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA 2010, 107:6328-6333.
76. Xing L., Kieff E. cis-Acting effects on RNA processing and Drosha cleavage prevent Epstein-Barr virus latency III BHRF1 expression. J Virol 2011, 85:8929-8939.